Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Core EBITDA

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 4.858.759.5238.6721.19

What is the latest EV/Core EBITDA ratio of NATCO PHARMA ?

The latest EV/Core EBITDA ratio of NATCO PHARMA is 4.85 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20254.85
Mar20248.75
Mar20239.52
Mar202238.67
Mar202121.19

How is EV/Core EBITDA of NATCO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 4.85
-44.57
Mar2024 8.75
-8.09
Mar2023 9.52
-75.38
Mar2022 38.67
82.49
Mar2021 21.19 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Core EBITDA ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹20,271.4 Cr -3.5% 1.2% 41.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,591.0 Cr 3.2% 12.4% 11.5% Stock Analytics
DIVIS LABORATORIES ₹183,512.0 Cr 1.8% 11% 10.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,850.0 Cr 3.8% 6.7% 35.5% Stock Analytics
CIPLA ₹113,884.0 Cr 6.2% 13.9% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹111,339.0 Cr 5.4% 8% 9.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3.5%

1.2%

41.1%

SENSEX

0.9%

-3.6%

-7.3%


You may also like the below Video Courses